drugset / Trial / NCT04140201
Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The investigator study evaluate the effect of different lipid lowering agents on the progression of diabetic retinopathy and other reduction of cardiovascular risk of diabetic patients
Timeline
- Start
- 2020-02
- Primary completion
- 2020-06
- Completion
- 2020-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Eicosapentanoic acid | Other / unclassified | — | — |
| Comparator | Fenofibrate | Small molecule | 200 mg | — |
| Comparator | Simvastatin | Small molecule | 40 mg | — |